Karyopharm Therapeutics Ownership | Who Owns Karyopharm Therapeutics?
Karyopharm Therapeutics Ownership Summary
Karyopharm Therapeutics is owned by 81.50% institutional investors, 4.46% insiders, and 14.04% retail investors. Commodore capital lp is the largest institutional shareholder, holding 17.83% of KPTI shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 3.89% of its assets in Karyopharm Therapeutics shares.
KPTI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Karyopharm Therapeutics | 81.50% | 4.46% | 14.04% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Commodore capital lp | 1.95M | 17.83% | $10.86M |
| Ra capital management | 1.92M | 17.53% | $10.68M |
| Adage capital partners gp | 1.81M | 16.52% | $10.06M |
| T. rowe price investment management | 1.54M | 14.10% | $8.59M |
| Goldman sachs group | 947.58K | 8.67% | $5.28M |
| Catalio capital management, lp | 897.71K | 8.21% | $5.00M |
| Ikarian capital | 733.43K | 6.71% | $4.09M |
| Vanguard group | 559.62K | 6.46% | $4.12M |
| Affinity asset advisors | 500.00K | 4.57% | $2.79M |
| Avidity partners management lp | 463.74K | 4.24% | $3.85M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Catalio capital management, lp | 897.71K | 1.04% | $5.00M |
| Avidity partners management lp | 463.74K | 0.87% | $3.85M |
| Commodore capital lp | 1.95M | 0.63% | $10.86M |
| Acorn capital advisors | 287.83K | 0.46% | $1.60M |
| Ikarian capital | 733.43K | 0.33% | $4.09M |
| Birchview capital, lp | 419.83K | 0.23% | $283.93K |
| Boxer capital management | 302.54K | 0.22% | $1.69M |
| Affinity asset advisors | 500.00K | 0.14% | $2.79M |
| Ra capital management | 1.92M | 0.11% | $10.68M |
| Soleus capital management | 440.00K | 0.10% | $2.45M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | 1.95M | 0.63% | 1.95M |
| Ra capital management | 1.92M | 0.11% | 1.92M |
| Adage capital partners gp | 1.81M | 0.02% | 1.39M |
| Goldman sachs group | 947.58K | 0.00% | 947.58K |
| Catalio capital management, lp | 897.71K | 1.04% | 754.73K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.17M | 0.00% | -5.28M |
| Deutsche bank ag\ | - | - | -1.27M |
| Kennedy capital management | - | - | -1.20M |
| Alphacentric advisors | - | - | -1.13M |
| Opaleye management | - | - | -930.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Commodore capital lp | 1.95M | 0.63% | 1.95M | $10.86M |
| Ra capital management | 1.92M | 0.11% | 1.92M | $10.68M |
| Millennium management | 420.57K | 0.00% | 420.57K | $2.34M |
| Acorn capital advisors | 287.83K | 0.46% | 287.83K | $1.60M |
| Eversept partners, lp | 276.17K | 0.08% | 276.17K | $1.54M |
Sold Out
| Holder | Change |
|---|---|
| Pittenger & anderson | -3.00 |
| Zurcher kantonalbank (zurich cantonalbank) | -6.00 |
| Farther finance advisors | -13.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Bruce g. allen investments | -22.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 65 | -14.47% | 8,911,554 | -5.86% | 81 | 2.94% | 40 | -13.04% | 6 | - |
| Dec 31, 2025 | 12 | -79.31% | 752,172 | -74.49% | 8 | 0.74% | 5 | -72.22% | - | -100.00% |
| Sep 30, 2025 | 18 | -62.50% | 552,924 | -86.33% | 6 | 0.29% | 5 | -79.17% | 3 | -50.00% |
| Jun 30, 2025 | 52 | 4.00% | 4,384,528 | -15.32% | 50 | 281.78% | 27 | 575.00% | 7 | -83.33% |
| Mar 31, 2025 | 51 | -45.74% | 5,312,129 | -91.28% | 4 | 0.17% | 4 | -88.89% | 43 | 86.96% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Small-Cap Value | 876.50K | 3.89% | 18.71K |
| T. Rowe Price U.S. SC Value Eq Tr-D | 611.05K | 2.71% | 25.74K |
| Vanguard US Total Market Shares ETF | 3.42M | 2.71% | -1.00 |
| Vanguard Total Stock Mkt Idx Inv | 509.13K | 2.26% | - |
| Vanguard Explorer Inv | 133.88K | 1.55% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 215.08K | 0.95% | - |
| AlphaCentric LifeSci Healthcare I | 1.13M | 0.90% | - |
| AlphaCentric Life Sciences & Hlthcare I | 1.13M | 0.89% | - |
| Kennedy Micro Cap | 1.03M | 0.81% | -22.77K |
| T. Rowe Price U.S. SC Value Eq Tr-Z | 50.09K | 0.60% | 50.09K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 14, 2026 | Poulton Stuart | EVP, Chief Development Officer | Sell | $3.83K |
| May 14, 2026 | Rangwala Reshma | EVP & Chief Medical Officer | Sell | $3.88K |
| May 14, 2026 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Sell | $3.08K |
| May 14, 2026 | Abate Kristin | Chief Accounting Officer | Sell | $503.50 |
| May 14, 2026 | Paulson Richard A. | President and CEO | Sell | $20.93K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 7 |
| 2026 Q1 | - | 9 |
| 2025 Q4 | - | 1 |
| 2025 Q3 | - | 9 |
| 2025 Q2 | - | 3 |
KPTI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools